Cite
HARVARD Citation
Shefner, J. et al. (2021). A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of Reldesemtiv In Patients With ALS. Amyotrophic lateral sclerosis and frontotemporal degeneration. 22 (3), pp. 287-299. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Shefner, J. et al. (2021). A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of Reldesemtiv In Patients With ALS. Amyotrophic lateral sclerosis and frontotemporal degeneration. 22 (3), pp. 287-299. [Online].